Valuation: IOL Chemicals and Pharmaceuticals Limited

Market Cap 49.77B 520M 446M 417M 382M 716M 726M 4.93B 1.92B 25B 1.95B 1.91B 82.69B P/E 2027 *
22.6x
P/E 2028 * 17.5x
Enterprise Value 49.77B 520M 446M 417M 382M 716M 726M 4.93B 1.92B 25B 1.95B 1.91B 82.69B EV / Sales 2027 *
1.81x
EV / Sales 2028 * 1.58x
Free-Float
33.91%
Yield 2027 *
-
Yield 2028 * -
1 day+3.51%
1 week+2.54%
Current month+15.97%
1 month+14.44%
3 months+42.73%
6 months+131.15%
Current year+106.14%
1 week 155.15
Extreme 155.15
175.5
1 month 143.55
Extreme 143.55
178.5
Current year 67.14
Extreme 67.14
179.65
1 year 67.14
Extreme 67.14
179.65
3 years 57.51
Extreme 57.51
179.65
5 years 54.44
Extreme 54.44
179.65
10 years 8.4
Extreme 8.4
179.68
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 14/11/2019
Director TitleAgeSince
Chairman 63 01/09/2007
Director/Board Member 34 29/05/2015
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.51%+2.54%+75.06%+128.26% 520M
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +1.51%+4.73%+35.84%+60.92% 380.04B
Weighted average by Cap. +1.14%+5.09%+44.27%+72.66%

Financials

2027 *2028 *
Net sales 27.42B 287M 246M 230M 210M 395M 400M 2.71B 1.06B 13.78B 1.08B 1.05B 45.57B 31.52B 329M 282M 264M 242M 454M 460M 3.12B 1.22B 15.84B 1.24B 1.21B 52.38B
Net income 2.2B 22.97M 19.68M 18.41M 16.85M 31.63M 32.05M 218M 84.83M 1.1B 86.26M 84.38M 3.65B 2.84B 29.68M 25.43M 23.79M 21.78M 40.87M 41.41M 281M 110M 1.43B 111M 109M 4.72B
Net Debt - -
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
3,095
Date Price Change Volume
21/08/26 ₹169.55 +3.51% 435,008
20/08/26 ₹163.80 +4.33% 153,811
19/08/26 ₹157.00 -1.66% 105,961
18/08/26 ₹159.65 -1.15% 76,249
17/08/26 ₹161.50 -2.33% 109,539
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
169.55INR
Average target price
197.00INR
Spread / Average Target
+16.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IOLCP Stock